Fundraising FoxEligard
1 known investors
Find your way into Eligard
Sign up to see every warm intro you have to Eligard
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eligard team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ELIGARD is a GnRH agonist medication in injectable form used to treat prostate cancer by reducing testosterone production. The product offers multiple dosing schedules for patients with metastatic castration-sensitive prostate cancer.
Investors · 1
Frequently asked questions
- What does Eligard do?
- ELIGARD is a GnRH agonist medication in injectable form used to treat prostate cancer by reducing testosterone production. The product offers multiple dosing schedules for patients with metastatic castration-sensitive prostate cancer.
- Who are Eligard's investors?
- Eligard's investors include HEALTHCARE ROYALTY PARTNERS.